All tumours are rare, but some are rarer than others
A partir des données de 94 registres des cancers en Europe sur la période 1995-2007, cette étude analyse l'évolution de l'incidence des cancers rares et celle de la survie (2 millions de cas de cancer rare)
The report from the RARECARE consortium in the Lancet Oncology, which updates the estimates of the burden of rare cancers in Europe raises questions well beyond its immediate subject matter: what is the purpose of cancer registries; how important is the quality of their data; how should we, in the 21st century, classify cancer?
The Lancet Oncology , commentaire, 2016